26.05.2020 RHÖN-KLINIKUM Aktiengesellschaft  DE0007042301

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft: German Federal Cartel Office approves planned acquisition of RHÖN-KLINIKUM AG by Asklepios Kliniken GmbH & Co. KGaA


 

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Offer/Mergers & Acquisitions
RHÖN-KLINIKUM Aktiengesellschaft: German Federal Cartel Office approves planned acquisition of RHÖN-KLINIKUM AG by Asklepios Kliniken GmbH & Co. KGaA

26.05.2020 / 17:25
The issuer is solely responsible for the content of this announcement.


Corporate News

Bad Neustadt a. d. Saale | 26 May 2020

RHÖN-KLINIKUM AG: German Federal Cartel Office approves planned acquisition of RHÖN-KLINIKUM AG by Asklepios Kliniken GmbH & Co. KGaA

RHÖN-KLINIKUM AG is advising that the German Federal Cartel Office has given its approval to the planned acquisition of up to 100 per cent of the interests in, and sole control over the Company by Asklepios Kliniken GmbH & Co. KGaA in the first review phase. This decision creates new legally valid majority relationships amongst the shareholders.

Stephan Holzinger, chairman of the Board of Management of RHÖN-KLINIKUM AG, said: "The decision by the Federal Cartel Office has created the basis for forging new paths at RHÖN-KLINIKUM AG with a new majority shareholder. RHÖN-KLINIKUM AG has an attractive portfolio of hospitals, medical excellence at the university level, innovative care models such as the campus approach, and numerous digitalisation projects that the Board of Management will continue to pursue steadfastly and with firm commitment. We continue to have an optimistic outlook for the future."

For more information on the takeover offer, please refer to the published Statement at www.rhoen-klinikum-ag.com/takeover-offer.

---------------------------------------------------

RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital Group offers excellent medical care with a direct link to universities and research facilities. Over 860,000 patients are treated every year at the five Group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg (UKGM) where more than 18,000 employees work. Key elements of the corporate strategy are entry into the promising future market of telemedicine with Medgate Deutschland, the innovative RHÖN Campus approach for cross-sector and future-oriented healthcare delivery in rural areas as well as the steadfast continuation of the gradual digital transformation.


Further information can be found on the Internet at www.rhoen-klinikum-ag.com

Please refer to our website should you need information regarding the subject of the corona virus.

Follow us on
www.twitter.com/rhoenklinikumag
www.xing.com/companies/rhön-klinikumag
www.youtube.com/rhönklinikumag


Contact:

RHÖN-KLINIKUM AG |Head of Corporate Communications and Marketing
Elke Pfeifer
T. +49 9771 65-12110 | [email protected]

RHÖN-KLINIKUM AG | Head of Investor Relations and Treasury
Julian Schmitt
T. +49 9771 65-12250 | [email protected]

RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale



26.05.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: [email protected]
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1055571

 
End of News DGAP News Service

1055571  26.05.2020 

fncls.ssp?fn=show_t_gif&application_id=1055571&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 1.211,08 1.232,91 1.303,90 1.360,16 1.402,01 1.446,09 1.463,98
EBITDA1,2 97,82 125,54 125,33 80,23 101,16 105,65 105,88
EBITDA-Marge3 8,08 10,18 9,61 5,90 7,22 7,31
EBIT1,4 38,70 64,94 56,80 10,60 30,52 36,11 40,40
EBIT-Marge5 3,20 5,27 4,36 0,78 2,18 2,50 2,76
Jahresüberschuss1 36,74 51,19 44,48 2,46 30,23 26,94 40,17
Netto-Marge6 3,03 4,15 3,41 0,18 2,16 1,86 2,74
Cashflow1,7 80,30 49,50 47,30 113,30 97,50 41,30 109,00
Ergebnis je Aktie8 0,53 0,73 0,65 0,02 0,42 0,38 0,58
Dividende8 0,22 0,29 0,00 0,00 0,00 0,15 0,35
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
Rhön-Klinikum
WKN Kurs in € Einschätzung Börsenwert in Mio. €
704230 10,900 Halten 729,89
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
18,17 28,00 0,64 18,63
KBV KCV KUV EV/EBITDA
0,58 6,70 0,50 6,30
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,15 0,00 0,00 05.06.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
08.05.2024 08.08.2024 07.11.2024 28.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
0,87% -2,85% 9,00% -16,15%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu RHÖN-KLINIKUM Aktiengesellschaft  ISIN: DE0007042301 können Sie bei EQS abrufen


Pflegeeinrichtungen , 704230 , RHK , XETR:RHK